Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome - Barton - 2012 - CA: A Cancer Journal for Clinicians
"According to the investigators, this study, along with earlier data,
supports the use of aspirin in the chemoprevention treatment of patients
with Lynch syndrome, although the dose and timing of use have not been
established. A CAPP3 study is planned that will investigate optimizing
the dose and duration. (More information can be found at www.CAPP3.org.)"
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.